Detailed description page of SalivaDB

This page displays user query in tabular form.

SAL_16954 details
Primary information
SALIDSAL_16954
Biomarker nameCotinine [HMDB0001046]
Biomarker TypeNA
Sampling MethodAdult (>18 years old); Gender-both
Collection MethodNA
Analysis MethodNA
Collection SiteSaliva
Disease CategoryHealthy
Disease/ConditionHealthy
Disease SubtypeNA
Fold Change/ Concentration<1.00 uM
Up/DownregulatedNA
ExosomalNA
OrganismHomo sapiens
PMID10080645
Year of Publication1999
Biomarker ID854019
Biomarker CategoryMetabolite
SequenceCN1[C@@H](CCC1=O)C2=CN=CC=C2
Title of studyValidation of an assay for the determination of cotinine and 3-hydroxycotinine in human saliva using automated solid-phase extraction and liquid chromatography with tandem mass spectrometric detection
Abstract of studyThe validation of a high-performance liquid chromatographic method for the simultaneous determination of low level cotinine and 3-hydroxycotinine in human saliva is reported. Analytes and deuterated internal standards were extracted from saliva samples using automated solid-phase extraction, the columns containing a hyper cross-linked styrene-divinylbenzene copolymer sorbent, and analysed by reversed-phase liquid chromatography with tandem mass spectrometric detection (LC-MS-MS). Lower limits of quantitation of 0.05 and 0.10 ng/ml for cotinine and 3-hydroxycotinine, respectively, were achieved. Intra- and inter-batch precision and accuracy values fell within +/-17% for all quality control samples, with the exception of quality control samples prepared at 0.30 ng/ml for 3-hydroxycotinine (inter-day precision 21.1%). Results from the analysis of saliva samples using this assay were consistent with subjects' self-reported environmental tobacco smoke (ETS) exposures, enhancing the applicability of cotinine as a biomarker for the assessment of low level ETS exposure.